Chris Stoeckert

Discussed on May 10, 2021 call. Very broad term that may be useful for manufacturers but maybe not for researchers. Maybe use more specific terms like enzyme-linked immunosorbent assay instead....

Discussed on Feb. 8, 2021. Concern with creating worker roles for every process that is done. Note that there are a couple worker roles like these but not clear we...

Discussed on June 6, 2022 OBI call. Consensus is that the parent should be 'material component separation'. Specimen collection would probably come before this process.

Started discussing on OBI Oct. 3, 2022 call. Question of whether these belong in OBIB (ontology for biobanking) rather than OBI. OBIB covers administration and management of biobanks so these...

Propose going for a very general definition: "An assay in which the activity of an enzyme is determined."

Note that some device terms needed may already be in OBIB. (e.g. vacutainer, cryovial). Happy to coordinate on them.

I agree with Bjoern about inclusion in OBI and like the approach of modeling these as outputs of assays. In OBI, we also have 'performance status value specification' http://purl.obolibrary.org/obo/OBI_0002356 which...

I don't think the labels of terms should be used to make these decisions. I don't think it is idiosyncratic at all to consider "Seated on chair or wheelchair pencil...

Discussed on June 6, 2022 call. At least part of this issue was addressed in https://github.com/obi-ontology/obi/pull/1499 Will be in next release.

@adbartni we can discuss this on the June 6, 2022 OBI dev call. Can you attend?